These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 15677517)

  • 1. Complement C3 is a risk factor for the development of diabetes: a population-based cohort study.
    Engström G; Hedblad B; Eriksson KF; Janzon L; Lindgärde F
    Diabetes; 2005 Feb; 54(2):570-5. PubMed ID: 15677517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Weight gain in relation to plasma levels of complement factor 3: results from a population-based cohort study.
    Engström G; Hedblad B; Janzon L; Lindgärde F
    Diabetologia; 2005 Dec; 48(12):2525-31. PubMed ID: 16283247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement C3 and C4 in plasma and incidence of myocardial infarction and stroke: a population-based cohort study.
    Engström G; Hedblad B; Janzon L; Lindgärde F
    Eur J Cardiovasc Prev Rehabil; 2007 Jun; 14(3):392-7. PubMed ID: 17568238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma levels of complement C3 is associated with development of hypertension: a longitudinal cohort study.
    Engström G; Hedblad B; Berglund G; Janzon L; Lindgärde F
    J Hum Hypertens; 2007 Apr; 21(4):276-82. PubMed ID: 17167524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of obesity-associated cardiovascular disease is related to inflammation-sensitive plasma proteins: a population-based cohort study.
    Engström G; Hedblad B; Stavenow L; Jonsson S; Lind P; Janzon L; Lindgärde F
    Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1498-502. PubMed ID: 15178569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammation-sensitive proteins and risk of atrial fibrillation: a population-based cohort study.
    Adamsson Eryd S; Smith JG; Melander O; Hedblad B; Engström G
    Eur J Epidemiol; 2011 Jun; 26(6):449-55. PubMed ID: 21424216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammation-sensitive plasma proteins, diabetes, and mortality and incidence of myocardial infarction and stroke: a population-based study.
    Engström G; Stavenow L; Hedblad B; Lind P; Eriksson KF; Janzon L; Lindgärde F
    Diabetes; 2003 Feb; 52(2):442-7. PubMed ID: 12540619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammation-sensitive plasma proteins are associated with future weight gain.
    Engström G; Hedblad B; Stavenow L; Lind P; Janzon L; Lindgärde F
    Diabetes; 2003 Aug; 52(8):2097-101. PubMed ID: 12882928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma complement C3 levels are associated with insulin secretion independently of adiposity measures in non-diabetic individuals.
    Fiorentino TV; Hribal ML; Andreozzi F; Perticone M; Sciacqua A; Perticone F; Sesti G
    Nutr Metab Cardiovasc Dis; 2015 May; 25(5):510-7. PubMed ID: 25813686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement factor 3 is associated with insulin resistance and with incident type 2 diabetes over a 7-year follow-up period: the CODAM Study.
    Wlazlo N; van Greevenbroek MM; Ferreira I; Feskens EJ; van der Kallen CJ; Schalkwijk CG; Bravenboer B; Stehouwer CD
    Diabetes Care; 2014 Jul; 37(7):1900-9. PubMed ID: 24760264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement component 3 (C3) as a biomarker for insulin resistance after bariatric surgery.
    Bratti LOS; do Carmo ÍAR; Vilela TF; Wopereis S; de Moraes ACR; Borba BGM; Souza LC; Filippin-Monteiro FB
    Clin Biochem; 2017 Jun; 50(9):529-532. PubMed ID: 28188738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing the inflammatory profiles for incidence of diabetes mellitus and cardiovascular diseases: a prospective study exploring the 'common soil' hypothesis.
    Bao X; Borné Y; Johnson L; Muhammad IF; Persson M; Niu K; Engström G
    Cardiovasc Diabetol; 2018 Jun; 17(1):87. PubMed ID: 29895294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute-phase proteins and incidence of diabetes: a population-based cohort study.
    Muhammad IF; Borné Y; Hedblad B; Nilsson PM; Persson M; Engström G
    Acta Diabetol; 2016 Dec; 53(6):981-989. PubMed ID: 27581604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex-Specific Associations Between Complement Component 3 and Component 4 Levels and Metabolic Syndrome in an Adult Population.
    Meng G; Li H; Li Y; Zhang Q; Liu L; Wu H; Xia Y; Bao X; Gu Y; Su Q; Fang L; Yang H; Yu F; Shi H; Sun S; Wang X; Zhou M; Jia Q; Song K; Chang H; Wu Y; Niu K
    Metab Syndr Relat Disord; 2018 Apr; 16(3):143-149. PubMed ID: 29596043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement C3 and C4, but not their regulators or activated products, are associated with incident metabolic syndrome: the CODAM study.
    Xin Y; Hertle E; van der Kallen CJH; Schalkwijk CG; Stehouwer CDA; van Greevenbroek MMJ
    Endocrine; 2018 Dec; 62(3):617-627. PubMed ID: 30132263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement C3 Associates With Incidence of Diabetes, but No Evidence of a Causal Relationship.
    Borné Y; Muhammad IF; Lorés-Motta L; Hedblad B; Nilsson PM; Melander O; de Jong EK; Blom AM; den Hollander AI; Engström G
    J Clin Endocrinol Metab; 2017 Dec; 102(12):4477-4485. PubMed ID: 29029276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term change in cholesterol in relation to inflammation-sensitive plasma proteins: a longitudinal study.
    Engström G; Hedblad B; Janzon L; Lindgärde F
    Ann Epidemiol; 2007 Jan; 17(1):57-63. PubMed ID: 17178329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum alpha1-antitrypsin but not complement C3 and C4 predicts chronic inflammation in hemodialysis patients.
    Borawski J; Naumnik B; Myśliwiec M
    Ren Fail; 2003 Jul; 25(4):589-93. PubMed ID: 12911163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C3 and C4 are strongly related to adipose tissue variables and cardiovascular risk factors.
    Nilsson B; Hamad OA; Ahlström H; Kullberg J; Johansson L; Lindhagen L; Haenni A; Ekdahl KN; Lind L
    Eur J Clin Invest; 2014 Jun; 44(6):587-96. PubMed ID: 24754458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory plasma markers and risk for venous thromboembolism.
    Sveinsdottir SV; Svensson PJ; Engström G
    J Thromb Thrombolysis; 2014; 38(2):190-5. PubMed ID: 24307292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.